These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 36880835)
1. RIOK3 promotes mTORC1 activation by facilitating SLC7A2-mediated arginine uptake in pancreatic ductal adenocarcinoma. Qin H; Sun R; Guo X; Fang L; Xu M; Teng Y; Zhen N; Wang A; Liu J Aging (Albany NY); 2023 Feb; 15(4):1039-1051. PubMed ID: 36880835 [TBL] [Abstract][Full Text] [Related]
2. RIOK3 promotes pancreatic ductal adenocarcinoma cell invasion and metastasis by stabilizing FAK. Xu M; Fang L; Guo X; Qin H; Sun R; Ning Z; Wang A Heliyon; 2022 Aug; 8(8):e10116. PubMed ID: 35982848 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2. Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517 [TBL] [Abstract][Full Text] [Related]
4. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma. Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910 [TBL] [Abstract][Full Text] [Related]
5. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4. Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191 [TBL] [Abstract][Full Text] [Related]
6. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395 [TBL] [Abstract][Full Text] [Related]
7. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma. Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376 [TBL] [Abstract][Full Text] [Related]
8. Citron Rho-Interacting Serine/Threonine Kinase Promotes HIF1a-CypA Signaling and Growth of Human Pancreatic Adenocarcinoma. Cong L; Bai Z; Du Y; Cheng Y Biomed Res Int; 2020; 2020():9210891. PubMed ID: 32185224 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation. Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774 [No Abstract] [Full Text] [Related]
10. Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Kimmelman AC; Hezel AF; Aguirre AJ; Zheng H; Paik JH; Ying H; Chu GC; Zhang JX; Sahin E; Yeo G; Ponugoti A; Nabioullin R; Deroo S; Yang S; Wang X; McGrath JP; Protopopova M; Ivanova E; Zhang J; Feng B; Tsao MS; Redston M; Protopopov A; Xiao Y; Futreal PA; Hahn WC; Klimstra DS; Chin L; DePinho RA Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19372-7. PubMed ID: 19050074 [TBL] [Abstract][Full Text] [Related]
11. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells. Li J; Ke J; Fang J; Chen JP J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239 [TBL] [Abstract][Full Text] [Related]
12. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763 [TBL] [Abstract][Full Text] [Related]
13. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830 [TBL] [Abstract][Full Text] [Related]
14. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer. Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599 [TBL] [Abstract][Full Text] [Related]
15. SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro. Zhao F; Huang Y; Zhang Y; Li X; Chen K; Long Y; Li F; Ma X Mol Biol Rep; 2022 Jul; 49(7):6613-6621. PubMed ID: 35552960 [TBL] [Abstract][Full Text] [Related]
16. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis. Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575 [TBL] [Abstract][Full Text] [Related]
17. Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway. Liu X; Tan X; Liu P; Wu Y; Qian S; Zhang X Oncol Res; 2018 Aug; 26(7):1123-1131. PubMed ID: 29386088 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1. Li S; Yan G; Yue M; Kang Z; Wang L Mol Med Rep; 2019 Feb; 19(2):1380-1387. PubMed ID: 30569091 [TBL] [Abstract][Full Text] [Related]
19. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028 [TBL] [Abstract][Full Text] [Related]
20. The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway. Zhang T; Ji D; Wang P; Liang D; Jin L; Shi H; Liu X; Meng Q; Yu R; Gao S Cancer Lett; 2018 Feb; 415():151-163. PubMed ID: 29233656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]